All News Items

Although most research laboratories at Duke University are shuttered to prevent future transmission of the Covid-19 coronavirus, one of the few to remain open houses a powerful machine that Duke re

Root Causes was founded by students aiming to create an organizational space to support the engagement of health professional students in service, education, and advocacy related to the social drivers of health. The goal is to shift the patient care paradigm to include elements like healthy food as a direct part of care provision.

Just six weeks ago, almost no one was talking about coronavirus. But by the third week of January, stories about a worrisome illness spreading in China had taken over news cycles across the world.

Dr. Francis has served as interim chair since July 2019 when the Division of Head and Neck Surgery & Communication Sciences in the Department of Surgery was elevated to department status. He formally served as chief of the division.

From the day she took office as dean of Duke University School of Medicine in 2017, Mary E.

More than 10 million people worldwide—about 1 percent of people over age 60—live with Parkinson’s disease. There are treatments that can help control symptoms, but there is no cure.

Imagine a doctor saying you need surgery to replace a heart valve, and if you don’t get it you will die from heart failure within two years. If you live in Honduras, once you get that diagnosis at a public hospital, the doctor will hand you a list of the items needed for the surgery: saline solution, sutures, gloves, an oxygenator, pain medication, and a heart valve. As the patient, it’s your responsibility to find—and buy-—the items on that list.

Dr. William G. Kaelin Jr., a Duke trustee and alumnus, was awarded the 2019 Nobel Prize for Physiology or Medicine.

Spanning Duke University and Duke Health, the Center for Advanced Genomic Technologies will use homegrown tools and techniques to discover potential therapies for human diseases from autism to

The Duke Human Vaccine Institute (DHVI) will remain at the lead of the nation’s effort to develop an HIV vaccine, receiving a third, seven-year grant from the N